Last reviewed · How we verify

NCT03847129

Assessments and Interventions for Hand Neuropathy in DM

Completed NA Last updated 20 February 2019
What this trial tests

NA trial testing Biofeedback training in Diabetes Mellitus in 39 participants. Completed in 2 June 2016.

Timeline
20 August 2015
Primary endpoint
2 June 2016
2 June 2016

Quick facts

Lead sponsorNational Cheng-Kung University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment39
Start date20 August 2015
Primary completion2 June 2016
Estimated completion2 June 2016
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Cheng-Kung University Hospital

Who can join

20 and older, any sex, with Diabetes Mellitus or Neuropathy, Diabetic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to investigate the effects of task-based biofeedback training compared with home-based programs on sensorimotor function and quality of life for diabetic patients with neuropathic hands. The investigators hypothesize that the task-based biofeedback training might have significant effectiveness for restoration of sensory function, precision pinch performance, hand dexterity and life quality for patients with diabetic neuropathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Biofeedback training

Trials testing the same drug.

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

Other National Cheng-Kung University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03847129.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing